Skip to main content
. 2017 Aug 11;7(8):e016224. doi: 10.1136/bmjopen-2017-016224

Table 3.

Subgroup analyses of the association between SSRI use and annual weight gain*

Non-user 1–2 prescriptions/year >2 prescriptions/year p For interaction
Western dietary pattern 0.026
  Low intake 0.00 0.11(−0.29–0.51) 0.14(−0.26–0.54)
  High intake 0.00 0.46 (0.05–0.88)† 0.84 (0.43–1.24)
Prudent dietary pattern 0.635
  Low intake 0.00 0.35(−0.07–0.78) 0.38(−0.02–0.78)
  High intake 0.00 0.23(−0.16–0.63) 0.61 (0.20–1.02)
Physical activity 0.039
  Sedentary 0.00 0.15(−0.34–0.63) 1.01 (0.52–1.50)
  Low 0.00 0.34(−0.13–0.82) 0.23(−0.27–0.72)
  Moderate/high 0.00 0.33(−0.27–0.94) 0.06(−0.49–0.61)
Smoking 0.002
  Non-smoker 0.00 −0.28(−0.73–0.16) 0.35(−0.03–0.72)
  Current or ex-smoker 0.00 0.44 (0.05–0.84) 0.66 (0.23–1.10)

*Bold values represent p<0.05.

†Models adjusted for age, gender, income, physical activity, smoking, depression status at baseline and follow-up. Stratifying variables were not adjusted in the corresponding models. Dietary pattern scores are dichotomised as low or high intake. Values represent regression coefficients (95% CI).

SSRI, selective serotonin reuptake inhibitor.